Abbott Laboratories (NYSE:ABT)
Abbott Laboratories (NYSE:ABT) is scheduled to release its Q2 2013 earnings results before the market open on Wednesday, July 17. Analysts expect the company to report revenue of $5.52 billion, and the average EPS estimate is for $0.44. Abbott reported $0.42 EPS for the first quarter, beating the consensus estimate of $0.41 by $0.01. Revenue for the period came in at $5.38 billion, compared to expectations for $5.42 billion. The company recently declared a quarterly dividend of $0.14 per share, payable on August 15, to stockholders of record July 15. The stock has a 1-year high of $38.77 and a 1-year low of $29.9761.
Setup a free account to get access to this article (no credit card required).Login required to continue reading.
